Dr. Bimal Chhajer, health and lifestyle expert at The Science And Art Of Living (SAAOL)If you are a diabetic, have been treated for coronary artery disease with angioplasty, stents or coronary artery bypass graft surgery and the signs and symptoms haven't gone away, you may be having diffuse small vessel disease. Small vessel or coronary microvascular disease is a condition in which small arteries in the heart that are not visible in angiograms become narrowed and cause signs and symptoms of heart disease such as angina chest pain. The large vessels in the heart can become narrowed or blocked through atherosclerosis, a condition in which fatty deposits build up in the arteries. In small vessel disease, the narrowing is in the heart’s small vessels due to which they can't expand properly when the patient is active resulting in inadequate supply of oxygen-rich blood. This inability to expand due to endothelial dysfunction may cause small vessels to actually become smaller when one is active or under emotional stress. The reduced blood flow through the small vessels causes angina or a heart attack and is usually diagnosed after a check for blockages in the main arteries of the heart show little or no narrowing in the large vessels but patient has angina symptoms. When small vessel disease is present along with large vessel disease, the condition may be suspected only when a patients has angina even after a successful angioplasty or bypass surgery.
Although anyone can have small vessel disease, it's more common in women and in people who have diabetes, are obese, smokers, have high cholesterol, high blood pressure, unhealthy diet and inactive lifestyle. Diabetics normally feel less pain and chances of painless myocardial infarction that may go unnoticed are more. Diffuse small vessel disease is more difficult to detect and less easily treatable and if left untreated can cause coronary artery spasm, heart attack, heart failure and sudden cardiac death. When in a symptomatic patient coronary angiogram does not show blockages in larger vessels, additional tests for smaller arteries narrowing such as Stress Thallium test imaging and Cardiovascular Cartography heart flow mapping may be of help.
Because the blocked or narrowed blood vessels that cause the disease are very small, angioplasty, stent and surgery are usually not helpful. Small vessel disease treatment involves medications to control the symptoms of narrowed small blood vessels such as Nitroglycerin, Nicorandil, Trimetazidine and Ranolazine. Beta blockers, Calcium channel blockers, Statins, Angiotensin-converting enzyme, Angiotensin II receptor blockers and Aspirin are often prescribed. Helpful dietary supplements are Coenzyme Q10 and L-arginine.
There has been some research on diabetic patients who have Coronary Artery Disease treated with External Counter Pulsation (ECP) therapy. ECP is an option for small vessel disease patients as it dilates the coronaries, opens dormant blood vessels and stimulates angiogenesis - thus should be more effective than stents and bypass in small vessel disease. An analysis of data from the International EECP Patient Registry concluded that “ECP is safe, well tolerated and associated with improvement in angina, functional status, and quality of life and that clinical benefit was maintained in most patients at one year” in diabetic patients. Many diabetics do not present for medical care until their heart disease has progressed due to small vessel disease, endothelial dysfunction and altered pain perception. ECP has been demonstrated to have a positive effect on endothelial function as well as in patient’s symptoms with small vessel disease. Patients with Coronary Artery Disease and diabetes often make excellent candidates for ECP Therapy since diabetic patients are at known increased risk for interventional complications.
ECP Therapy has been demonstrated to increase a patient’s cardiac output and perfusion to all the organs throughout the body, which would absolutely be beneficial in diabetic patients as diabetes is a multi-organ disease. It makes sense that diabetic patients improve with ECP since many of the positive benefits associated with ECP are similar to the benefits of physical exercise and research has demonstrated that physical exercise definitely helps diabetic patients. Though more research is needed it is believed that symptoms of diabetic neuropathy improve in patients who undergo ECP Therapy.
It is not unusual to see a drop of about 20mg/dL in blood sugar after completing of one hour of ECP. Reports from ECP centres suggest that patients who have undergone ECP not only have better control of their blood glucose levels but have also had their physician lower (or in some cases, completely eliminate) the dosage of diabetic medication needed to maintain an optimum blood sugar level; this is not surprising since the benefits of EECP have a similar systemic effect to that of physical exercise.
Another research reported EDTA Chelation Therapy to benefits with up to 50% prevention of recurrent heart attacks and 43 percent reduction in all causes death rate. Dr. Gervasio Lamas, principal investigator of the National Institute of Health (USA) sponsored Trial to Assess Chelation Therapy (TACT) presented results at the American Heart Association meeting in Los Angeles in 2012. The randomized, placebo-controlled study was conducted on 1,708 patients in 134 medical centres across the U.S. and Canada by cardiologists from prestigious medical schools at a cost of $30 million. Statistical analysis showed intravenous chelation therapy decreased subsequent cardiac events when compared to a control group of similar patients who received placebo. There were fewer deaths, fewer heart attacks, and fewer strokes, less need for cardiovascular surgery, and fewer hospitalizations for heart problems. Chelation therapy was shown to be safe, without any serious side effects. Patients experienced increasing benefits during the five years they were studied up to. Diabetic patients appeared to do better than the non-diabetic patients. This could be due to micro circulation being affected more than macro circulation in diabetic patients.